Rachel E M Cramton1, Nancy E Gruchala. 1. Department of Pediatrics, University of Arizona College of Medicine, Tucson, Arizona 85724, USA. rcramton@peds.arizona.edu
Abstract
PURPOSE OF REVIEW: This review will summarize the symptoms, evaluation, and treatment of neonatal and iatrogenic withdrawal syndromes. RECENT FINDINGS: Buprenorphine is emerging as the drug of choice for maintaining opioid-dependent women during pregnancy, because of its association with less severe withdrawal symptoms. Recent findings suggest it may be the drug of choice for treating the opioid-exposed neonate as well. SUMMARY: Healthcare workers should be cognizant of the risk factors for neonatal abstinence syndrome (NAS), as well as its symptoms, so that nonpharmalogic and pharmacologic therapies can be initiated. With increased emphasis on pain control in children, it is likely that iatrogenic withdrawal will continue to be a concern, and healthcare workers should understand the similarities and differences between this and NAS.
PURPOSE OF REVIEW: This review will summarize the symptoms, evaluation, and treatment of neonatal and iatrogenic withdrawal syndromes. RECENT FINDINGS:Buprenorphine is emerging as the drug of choice for maintaining opioid-dependent women during pregnancy, because of its association with less severe withdrawal symptoms. Recent findings suggest it may be the drug of choice for treating the opioid-exposed neonate as well. SUMMARY: Healthcare workers should be cognizant of the risk factors for neonatal abstinence syndrome (NAS), as well as its symptoms, so that nonpharmalogic and pharmacologic therapies can be initiated. With increased emphasis on pain control in children, it is likely that iatrogenic withdrawal will continue to be a concern, and healthcare workers should understand the similarities and differences between this and NAS.
Authors: Sebastiaan C Goulooze; Erwin Ista; Monique van Dijk; Thomas Hankemeier; Dick Tibboel; Catherijne A J Knibbe; Elke H J Krekels Journal: CPT Pharmacometrics Syst Pharmacol Date: 2019-10-15
Authors: Kavita Batra; Patricia Cruz; Chad L Cross; Neeraj Bhandari; Farooq Abdulla; Jennifer R Pharr; Mark P Buttner Journal: Int J Environ Res Public Health Date: 2020-12-30 Impact factor: 3.390
Authors: Eiad Habib; Abdul Hakim Almakadma; Mohieddin Albarazi; Somiya Jaimon; Rayd Almehizia; Abdullah Al Wadai; Raja Abouelella Journal: J Saudi Heart Assoc Date: 2021-10-15